June 2025 in “Patient Preference and Adherence” This study examined Chinese adult patients' discussions on social media about JAK inhibitors for alopecia areata, highlighting significant interest in these treatments but also concerns about efficacy, relapse, side effects, and the emotional impact of the condition.
May 2025 in “Journal of Cosmetic Dermatology” This research emphasizes the importance of integrating pre-treatment psychological assessments for individuals considering finasteride, highlighting that these assessments could help identify those prone to nocebo responses, potentially reducing adverse symptom development more related to cognitive vulnerabilities than to the drug itself.
April 2025 in “Journal of Dermatology for Physician Assistants” This narrative highlights a study underscoring that vitiligo and alopecia areata are complex autoimmune conditions, often misclassified as cosmetic, which can hinder patients' access to necessary treatments despite their profound impact on quality of life and associated comorbidities.
March 2025 in “Journal of Cosmetic Dermatology” This study found that reports of suicidal ideations linked to oral finasteride were significantly higher in 2013–2018 and 2019–2023 compared to 2006–2011, potentially due to increased awareness of post-finasteride syndrome from 2012 onward. No such signals were seen with oral dutasteride.
This review highlights that alopecia areata is influenced by genetic, autoimmune, and environmental factors, with emerging treatments like JAK-2 inhibitors showing promise for severe cases.
January 2025 in “JDDG Journal der Deutschen Dermatologischen Gesellschaft” This study surveyed German dermatologists about treating children and adolescents with alopecia areata, revealing significant emotional challenges like bullying and low self-esteem, dissatisfaction with available treatments, and a need for both psychological support and new therapeutic guidelines.
November 2024 in “Journal of Investigative Dermatology” Inherited ichthyosis negatively impacts quality of life, affecting daily activities, self-image, and reproductive decisions.
November 2024 in “IP Indian Journal of Clinical and Experimental Dermatology” In this study, researchers reported that alopecia areata significantly impacts quality of life, with effects ranging from small to very large, especially for those with longer disease duration, highlighting the importance of psychological evaluation and support for affected patients.
September 2024 in “JEADV Clinical Practice” In this study, researchers analyzed French social media posts and found that alopecia areata profoundly impacts patients' quality of life, affecting them physically, psychologically, socially, and financially, often driving them to seek support online.
August 2024 in “International Journal of Ayurveda and Pharma Research” This study provides a comprehensive review of Ayurvedic insights into Darunaka, suggesting that its management principles can still improve quality of life by addressing underlying pathophysiology.
July 2024 in “Dermatology Practical & Conceptual” This study found that patients with SARS-CoV-2 associated telogen effluvium experienced hair loss sooner after infection compared to telogen effluvium from other causes, with distinct dermoscopic findings aiding diagnosis.
June 2024 in “British Journal of Dermatology” This narrative focuses on the experiences of two women with permanent chemotherapy-induced alopecia, highlighting the severe psychological and social impact along with dissatisfaction over pre-treatment information about hair loss, which they initially believed to be temporary.
June 2024 in “Trends in Urology & Men s Health” This study explores the controversial condition known as post‐finasteride syndrome, observed in some men who experience lasting sexual, neurological, and psychological side effects after stopping finasteride, emphasizing its rarity and the lack of proven treatments.
June 2024 in “IP Indian journal of clinical and experimental dermatology” This review explored the causes and treatment options for hair loss, highlighting current therapies like minoxidil and hair transplants, while also emphasizing the need for new approaches such as gene therapies and advanced delivery methods for improved outcomes.
May 2024 in “Psychotherapie Forum” In this single-case study, researchers found that a combination of behavior and hypnotherapy led to positive psychological changes in a patient with Alopecia areata but did not result in hair regrowth, suggesting psychosomatic approaches may not address the hair loss mechanism.
May 2024 in “Brazilian Journal of Hair Health” This article discusses how 5-alpha-reductase inhibitors like finasteride and dutasteride are used to treat androgenetic alopecia, while highlighting the ongoing debate over their potential side effects, including sexual dysfunction and psychological issues.
March 2024 in “CRC Press eBooks” In this study, telogen effluvium is characterized as a common condition in women involving sudden hair shedding due to hair follicles prematurely entering the telogen phase, with potential triggers including fever, childbirth, and stress.
This review explores the risk factors, associated comorbidities, and psychological impacts of early-onset androgenetic alopecia, highlighting its complexity and potential implications for treatment response and overall health.
February 2024 in “Recima21” This study explored the connections between Covid-19 and hair loss issues like telogen effluvium and alopecia areata, highlighting the virus's potential trigger effect and underscoring the importance of comprehensive post-Covid-19 treatment strategies that consider immune, psychological, and hair cycle factors.
February 2024 in “Journal of the European Academy of Dermatology and Venereology” In this study, 44.7% of individuals with alopecia in a European general population sample did not consult a healthcare professional, with perspectives on alopecia's impact varying across types.
This study found that adult acne is more prevalent among females in the Indian population, with common factors including topical steroid use and hyperandrogenism, and that it frequently results in scarring and psychological stress, underscoring the need for early treatment.
December 2023 in “Journal of family medicine and primary care” This study in Saudi Arabia found that 59.70% of participants experienced hair shedding during or after COVID-19, with significant risk factors including being female, having a history of telogen effluvium, and receiving COVID-19 antiviral treatment.
This study found a high prevalence of stress-related hair loss in Al Majma'ah, Saudi Arabia, particularly among females and individuals aged 31-40, with significant associations between hair loss and stress, psychosocial challenges, and sociodemographic factors.
October 2023 in “Journal of the European Academy of Dermatology and Venereology” In this study, a Delphi survey among 441 European dermatology patients identified psychological impacts as the most significant issues affecting their lives, underscoring the need for psychological support in managing dermatological diseases.
August 2023 in “International Ayurvedic medical journal” In this thesis, the authors concluded that various lifestyle factors such as poor dietary habits, stress, and inadequate hair care habits contribute significantly to hair fall, or Khalitya, highlighting the role of lifestyle changes in mitigating hair loss.
August 2023 in “Tzu Chi Medical Journal” This study at a medical center in Eastern Taiwan found that female alopecia has diverse causes, including nutrient deficiencies, autoimmune diseases, psychological stress, thyroid conditions, and COVID-19 vaccination, with iron deficiency affecting 70.3% of cases.
August 2023 in “Zenodo (CERN European Organization for Nuclear Research)” This study examined Indian women with Polycystic Ovarian Syndrome and found that those using a disengagement coping style experience higher levels of depression, anxiety, and stress, which negatively impacts their quality of life.
July 2023 in “Journal of Cosmetic Dermatology” This study investigated AGA professionals' perspectives and found that 42% were misled by commercial influences, underestimated these biases' extent, and faced ethical challenges in treatment due to societal pressures and misinformation, highlighting a need for evidence-based guidance and research scrutiny tools.
June 2023 in “Diyala Journal of Medicine” In this Baquba city study, alopecia areata was more prevalent among males aged 21 to 30, with most experiencing single lesions on the head, recurring cases, and a history of psychological stress.
June 2023 in “Diyala Journal of Medicine” In this cross-sectional study of 100 patients in Baquba, researchers found that alopecia areata was more prevalent in males aged 21-30, with single lesion patches mainly appearing on the head, and observed a significant association with personal stress history.